Success Story: We Helped an Indian Research Scientist Secure EB1A Approval with Premium Processing Service In Just 17 Days

Client’s Testimonial:

“This is truly fantastic news! I sincerely appreciate all your help and support with my I-140 application.”

On January 24^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the Field of Molecular Virology (Approval Notice).

General Field: Molecular Virology

Position at the Time of Case Filing: Research Scientist

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: January 24^th, 2025

Processing Time: 17 days (Premium Processing Requested)

Case Summary:

NAILG is pleased to announce the approval of an EB-1A petition for our client, an accomplished molecular virologist with a Ph.D. in virology. The client has established himself as one of the few leading specialists in the evolution of respiratory viruses, with a particular focus on SARS-CoV-2 in immunocompromised hosts. His research has provided critical insights into how viral mutations emerge and spread, directly informing global pandemic response efforts.

Advancing the Understanding of Viral Evolution

The client’s investigations into viral persistence and mutation mechanisms have been widely recognized for their impact on public health. His work clarifies the role of host immune response in shaping viral evolution, challenging previous assumptions about antiviral treatments such as remdesivir. This line of research is crucial for anticipating future viral variants, developing effective vaccines, and protecting vulnerable populations. Importantly, the significance of his findings has reached beyond academia, earning coverage in international media outlets, underscoring his role as a trusted authority in virology.

Evidence of Accomplishments

The petition highlighted his extensive record of scholarly contributions, including:

44 peer-reviewed journal articles (8 first-authored and 7 co-first-authored), 6 abstracts, and 1 preprint.
His research has been cited 4,450 times, reflecting its influence and applicability in the field.
He has conducted at least 26 peer reviews for respected scientific journals, further confirming his recognition as an expert in his domain.

Recognition and Support

The petition was strengthened by four expert recommendation letters, which attested to the originality and impact of his contributions. These letters emphasized how his work has shaped scientific understanding of viral evolution and informed both clinical and public health practices.

“In conclusion, [Client] contributes valuable research for combating and understanding infectious diseases, especially among individuals with weakened immune systems. For the development of new and effective drugs and the advancement of medical research as a whole, the country must support its work.”

A Successful Outcome

USCIS approved the EB-1A petition after reviewing the strong evidence of his extraordinary ability and international influence in virology. This approval recognizes not only his achievements to date but also the national and global importance of his ongoing research.

At NAILG, we are proud to have supported this client in preparing a strong and well-documented petition. His success stands as a testament to his exceptional qualifications and to our firm’s expertise in navigating complex immigration matters. We look forward to seeing his continued contributions to advancing the scientific and medical understanding of viral evolution.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.